背景一、现状写实西南合成制药厂始建于六十年代初,是当时西南地区最大的原料药生产基地,为我国医药事业的发展作出过重要贡献。九十年代初,该企业进入不景气状态。为了摆脱困境,1993年初,由其独家发起,成立了西南合成制药股份有限公司,并将其生产经营性净资产8500万元折价入股,同时采取定向募集方式,向社会法人平价发行4500万股,并于 Background First, the status quo reality Southwest Synthetic Pharmaceutical Factory was founded in the early 1960s, was the largest production base of APIs in the Southwest at that time, made an important contribution to the development of China's pharmaceutical industry. The early 90s, the company entered a downturn. In order to get out of the predicament, in early 1993, initiated and established by itself, Southwest Synthetic Pharmaceutical Co., Ltd., and its production and operation of net assets of 85 million yuan at a discount to shares, at the same time to take targeted way to raise 45 million shares issued to social corporate parity, And at